Showing results (631-640 of 743) with videos related to

Sort By:
Pageof 75
BMJ Open Gastroenterology|May 13, 2022
Post-transplant biliary complications: advances in pathophysiology, diagnosis, and treatmentMatthew Fasullo, Milan Patel, Lauren Khanna, et al.
BMJ Open Gastroenterology|October 12, 2017
Replacement of warfarin with a novel oral anticoagulant in endoscopic mucosal resection: a multicentre, open-label, randomised controlled trialTakuya Yamada, Akiko Kada, Toshio Uraoka, et al.
BMJ Open Gastroenterology|October 12, 2017
Efficacy of individualised diets in patients with irritable bowel syndrome: a randomised controlled trialAther Ali, Theresa R Weiss, Douglas McKee, et al.
BMJ Open Gastroenterology|July 6, 2019
Pancreatic cancer 'mismatch' in Lynch syndromeAndrew E Hendifar, Brent K Larson, Rebecca Rojansky, et al.
BMJ Open Gastroenterology|July 6, 2019
Factors associated with renal dysfunction in hepatitis C-related cirrhosis and its correlation with Child-Pugh scoreHamza Waqar Bhatti, Umama Tahir, Noman Ahmed Chaudhary, et al.
BMJ Open Gastroenterology|July 6, 2019
Non-alcoholic fatty liver disease with obesity as an independent predictor for incident gastric and colorectal cancer: a population-based longitudinal studyMasahide Hamaguchi, Yoshitaka Hashimoto, Akihiro Obora, et al.
BMJ Open Gastroenterology|July 6, 2019
Methylated SEPTIN9 plasma test for colorectal cancer detection may be applicable to Lynch syndromeMegan P Hitchins, Ingrid P Vogelaar, Kevin Brennan, et al.
BMJ Open Gastroenterology|July 6, 2019
Detection of hiatal hernias: comparison of high-resolution manometry and physician reported in an obese-predominant populationSardar Momin Shah-Khan, Fahad Chaudhary, Abdelhai Abdelqader, et al.
BMJ Open Gastroenterology|May 3, 2017
Corticosteroid use and mortality risk in patients with perforated colonic diverticular disease: a population-based cohort studyL H A Broersen, E Horváth-Puhó, A M Pereira, et al.
BMJ Open Gastroenterology|June 20, 2018
Evaluation of amnion-derived mesenchymal stem cells for treatment-resistant moderate Crohn's disease: study protocol for a phase I/II, dual-centre, open-label, uncontrolled, dose-response trialShinsuke Otagiri, Shunsuke Ohnishi, Arisa Miura, et al.
Pageof 75